Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic's Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor … [Read More...] about Medtronic reports first real-world data on smart insulin pen system
Main Content
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Of the hundreds of millions of people living with diabetes, the vast majority live with type 2. Dexcom (Nasdaq:DXCM) wants to make sure they have the tools to manage that. The International Diabetes Federation says that more than 90% of people … [Read More...] about Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Modular Medical announces $12M private placement
Modular Medical (Nasdaq:MODD) announced today that it entered into definitive subscription agreements worth proceeds of approximately $12 million. The insulin patch pump maker company entered the agreements with institutional and accredited … [Read More...] about Modular Medical announces $12M private placement
Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic's Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor … [Read More...] about Medtronic reports first real-world data on smart insulin pen system
Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Insulet (Nasdaq:PODD) today announced new Omnipod 5 clinical data highlighting the transition from multiple daily injections (MDI). Investigators shared data from the RADIANT study at the 18th International Conference on Advanced Technologies … [Read More...] about Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for type 2 diabetes. San Diego-based Tandem won FDA clearance for its Control-IQ+ next-generation algorithm for type 2 diabetes … [Read More...] about Tandem has positive data for automated insulin delivery in type 2 diabetes population
![The NovoPen Echo smart insulin pen now works with Dexcom CGM. [Image from Novo Nordisk]](https://www.drugdeliverybusiness.com/wp-content/uploads/2022/11/Novo-Nordisk-NovoPen-Echo-Smart-Insulin-Pen-Abbott.jpg)
Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors (CGMs). The company shared its updates at the 18th International Conference on Advanced Technologies and Treatments for … [Read More...] about Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
Dexcom study finds that providers prefer tech over medication for type 2 diabetes
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments. The "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East" surveyed 2,500 people. It featured … [Read More...] about Dexcom study finds that providers prefer tech over medication for type 2 diabetes
Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in the U.S. Control-IQ+ represents the next generation of the company's advanced hybrid closed-loop insulin … [Read More...] about Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Ypsomed, CamDiab launch iOS app for automated insulin delivery system
Ypsomed and CamDiab today announced the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms. The app comprises part of the mylife Loop automated insulin delivery system. The iOS launch allows people with type 1 … [Read More...] about Ypsomed, CamDiab launch iOS app for automated insulin delivery system
Insulet CTO Mark Field departs for new opportunities
Insulet (Nasdaq:PODD) announced today that SVP and Chief Technology Officer Mark Field is departing the company. Field left the automated insulin delivery technology developer to pursue other opportunities, effective March 14, according to an SEC … [Read More...] about Insulet CTO Mark Field departs for new opportunities
In case you missed it
- Insulet expands Omnipod 5 to more countries, prices $450M offering
- Sequel Med Tech makes first CGM integration with Abbott for automated insulin pump
- Vivani reports first human GLP-1 implant for weight loss in adults
- Trinity Biotech to undergo strategic realignment, focus on CGM development
- Vivani to spin out neurostim business, focus on GLP-1 implant
- Dexcom receives FDA warning letter
- Real-world data backs Insulet Omnipod 5 in children
- Baxter warns on certain infusion pumps with missing screws
- Senseonics expects to double global patient base in 2025, progresses with pump integration
- Pump shipments increase by 25% in Q4 sales beat for Tandem
- Senseonics inks diabetes management software deal for Eversense 365
- ViCentra picks former Medtronic leader as CEO to expand access to automated insulin delivery tech
- Abbott inks first Lingo retail deal with Amazon
- FDA clears Tandem Diabetes Care’s next-gen automated insulin delivery algorithm for type 2 diabetes
- Data outlines need for CGM study design guidelines
Clinical Trials
Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic’s Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor (CGM). Data showed how the system, designed for people with diabetes using multiple daily injections (MDI) when used as intended, […]
Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Insulet (Nasdaq:PODD) today announced new Omnipod 5 clinical data highlighting the transition from multiple daily injections (MDI). Investigators shared data from the RADIANT study at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. The randomized controlled trial evaluated the direct transition from MDI to automated insulin delivery (AID). Insulet […]
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for type 2 diabetes. San Diego-based Tandem won FDA clearance for its Control-IQ+ next-generation algorithm for type 2 diabetes at the end of last month. Just yesterday, the company announced the launch of the algorithm. Control-IQ+ represents the next generation of the […]
Vivani reports first human GLP-1 implant for weight loss in adults
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 clinical trial. This news comes just one day after Vivani announced plans to spin off its neurostimulation business to focus on its GLP-1 implants. The company also announced full enrollment in LIBERATE-1, achieved in just four weeks after the […]
Data supports Medtronic Prevail paclitaxel-coated balloon
Medtronic (NYSE: MDT) announced results from a registry highlighting the effectiveness of the Prevail drug-coated balloon (DCB). Dr. Sacharias von Koch of the dept. of cardiology and clinical sciences at Lund University, Skåne University Hospital in Sweden presented findings from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) at Cardiovascular Research Technologies (CRT) 2025 in […]
